Write For Us

FDA panel rejects attempt to use psychedelic drug for PTSD treatment

Sponsored Post Vitamin D2 Canada Persia
11 Views
Published
A key FDA advisory committee rejected the use of a psychedelic drug to help patients struggling with PTSD, questioning its safety and effectiveness. The FDA must now decide whether it will follow suit and reject the use of what's known as MDMA. Some patients and researchers had long hoped the government would approve it. Science correspondent Miles O’Brien reports.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
TikTok: https://www.tiktok.com/@pbsnews
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Facebook: http://www.pbs.org/newshour

Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
Category
U.S. & Canada
Tags
mdma, mdma ptsd, ptsd
Sign in or sign up to post comments.
Be the first to comment